Tens of thousands of Kaiser Permanente workers in California and Hawaii have gone on strike, demanding safer staffing levels ...

Insurers are cutting coverage for costly GLP-1 weight loss drugs, sparking backlash from advocates who say they're vital for ...

Novo Nordisk is paying $240 million up front for global rights to zaltenibart, an Omeros drug that blocks the MASP-3 protein to treat diseases caused by excessive activity of the complement system.

Kailera Therapeutics executives say their lead drug candidate could become best in a category of obesity drugs currently led by a blockbuster Eli Lilly product, and the biotech has secured $600 ...

Interoperability doesn’t start with a 9-1-1 call. It begins with a commitment to data quality, documentation integrity, and adherence to national standards across the system. For EMS, this means ...

Stephanie Baum is the Director of Special Projects for MedCityNews. She graduated from Franklin & Marshall College in Pennsylvania and has worked across radio, print and video. She's worked for Dow ...